Skip to main content
logo
ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
21.43
+0.54 (2.58%)
At close: Jun 3, 2026, 4:00 PM EDT
20.46
-0.97 (-4.52%)
After-hours: Jun 3, 2026, 4:22 PM EDT

ACADIA Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
375.65391226.45-61.29-215.98-167.87
Depreciation & Amortization
11.811.7615.885.55-3.34
Stock-Based Compensation
55.4552.1467.0566.4268.263.62
Other Adjustments
-3.86-255.3-155.82-12.12-4.250.08
Change in Receivables
-34.67-43.54-2.35-39.272.26-15.06
Changes in Inventories
-7.67-18.2-49.55-28.812.42-4.21
Changes in Accounts Payable
-5.85-5.29-1.354.85.87-1.62
Changes in Accrued Expenses
4.41-19.2771.0693.1724.31-8.46
Changes in Other Operating Activities
-23.24-3.47-13.66-11.763.144.52
Operating Cash Flow
123.49109.84157.7216.7-114.04-125.66
Operating Cash Flow Growth
-17.10%-30.36%844.31%---
Capital Expenditures
-9.9-4.69-0.52-0.05--1.12
Sale of Property, Plant & Equipment
--146.52---
Purchases of Intangible Assets
--98.84--40--
Purchases of Investments
-551.56-692.57-505.1-369.99-363.17-492.8
Proceeds from Sale of Investments
449.23493.53328.57442.03436.42422.82
Investing Cash Flow
-112.23-302.56-30.543273.24-71.1
Issuance of Common Stock
52.2849.886.8525.138.218.16
Net Common Stock Issued (Repurchased)
52.2849.886.8525.138.218.16
Financing Cash Flow
52.2849.886.8525.138.218.16
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.060.03-0.09-0.020.010.01
Net Cash Flow
63.59-142.82133.9373.81-32.59-178.59
Free Cash Flow
113.59105.15157.216.65-114.04-126.78
Free Cash Flow Growth
8.03%-33.11%844.01%---
FCF Margin
10.37%9.81%16.41%2.29%-22.05%-26.19%
Free Cash Flow Per Share
0.660.620.940.10-0.71-0.79
Levered Free Cash Flow
345.2351.85248.311.62-180.25-175.41
Unlevered Free Cash Flow
233.59255.88224.37-25.21-190.52-178.34
SEC Filings: 10-K · 10-Q